Old Registry DNA Vetcare Ltd 15944238 false 2024-09-09 2025-07-31 2025-07-31 The principal activity of the company is that of a holding company. Digita Accounts Production Advanced 6.30.9574.0 false true false 15944238 2024-09-09 2025-07-31 15944238 2025-07-31 15944238 core:RetainedEarningsAccumulatedLosses 2025-07-31 15944238 core:ShareCapital 2025-07-31 15944238 core:CurrentFinancialInstruments core:WithinOneYear 2025-07-31 15944238 core:Non-currentFinancialInstruments 2025-07-31 15944238 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-07-31 15944238 bus:SmallEntities 2024-09-09 2025-07-31 15944238 bus:Audited 2024-09-09 2025-07-31 15944238 bus:FullAccounts 2024-09-09 2025-07-31 15944238 bus:SmallCompaniesRegimeForAccounts 2024-09-09 2025-07-31 15944238 bus:RegisteredOffice 2024-09-09 2025-07-31 15944238 bus:Director1 2024-09-09 2025-07-31 15944238 bus:Director2 2024-09-09 2025-07-31 15944238 bus:Director3 2024-09-09 2025-07-31 15944238 bus:PrivateLimitedCompanyLtd 2024-09-09 2025-07-31 15944238 core:Subsidiary1 2024-09-09 2025-07-31 15944238 core:Subsidiary1 1 2024-09-09 2025-07-31 15944238 core:Subsidiary1 2 2024-09-09 2025-07-31 15944238 core:Subsidiary1 countries:AllCountries 2024-09-09 2025-07-31 15944238 1 2024-09-09 2025-07-31 15944238 1 2024-09-09 2025-07-31 15944238 countries:EnglandWales 2024-09-09 2025-07-31 iso4217:GBP xbrli:pure

Registration number: 15944238

Old Registry DNA Vetcare Ltd
Annual Report and Filleted Abridged Financial Statements
for the Period from 9 September 2024 to 31 July 2025

Old Registry DNA Vetcare Ltd

Contents

Abridged Balance Sheet | 1
Notes to the Abridged Financial Statements | 2 to 4

Old Registry DNA Vetcare Ltd

(Registration number: 15944238)
Abridged Balance Sheet as at 31 July 2025

| Note | 2025 £
Fixed assets |  |
Investments | 4 | 3,063,989
Creditors: Amounts falling due within one year |  | (2,461,989)
Net assets |  | 602,000
Capital and reserves |  |
Called up share capital |  | 1,000
Profit and loss account |  | 601,000
Total equity |  | 602,000

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Profit and Loss Account has been taken.

All of the Company’s members have consented to the preparation of an Abridged Profit and Loss Account and an Abridged Balance Sheet in accordance with Section 444(2A) of the Companies Act 2006.

Approved and authorised by the Board on 29 May 2026 and signed on its behalf by:

Mr A G Van Heerden

Director

Mr S D Walker

Director

Mr D Mayhew

Director

Old Registry DNA Vetcare Ltd

Notes to the Abridged Financial Statements for the Period from 9 September 2024 to 31 July 2025

1 | General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
105 Humber Road
Blackheath
London
SE3 7LW

These financial statements were authorised for issue by the Board on 29 May 2026.

2 | Accounting policies

Statement of compliance

These abridged financial statements were prepared in accordance with Financial Reporting Standard 102 Section 1A 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006.

Basis of preparation

These abridged financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Disclosure of long or short period

The reporting period has been shortneded to 31 July 2025 to coincide with the reporting period of the company's parent DNA Vetcare Limited.

Going concern

The financial statements have been prepared on a going concern basis. Of the company's liabilities amounts are owed to the directors or companies wholly under the control of directors. The directors have agreed to not demand repayment of these amounts so as to not jeopardise the future of the company.

Audit report

The Independent Auditor's Report was unqualified. The name of the Senior Statutory Auditor who signed the audit report on 29 April 2026 was Duncan Nicholas FCA, who signed for and on behalf of Moore Scarrott Audit Limited.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax is recognised on temporary differences arising between the tax bases of assets and liabilities and their carrying amounts in the financial statements and on unused tax losses or tax credits in the company. Deferred income tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.
The carrying amount of deferred tax assets are reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit.

Old Registry DNA Vetcare Ltd

Notes to the Abridged Financial Statements for the Period from 9 September 2024 to 31 July 2025

Investments

Investments in equity shares where the fair value can be measured reliably are initially measured at fair value, with changes in fair value recognised in the profit or loss account. Investments in equity shares where fair value cannot be measured reliably are measured at cost less impairment.

3 | Staff numbers

The average number of persons employed by the company (including directors) during the period, was 3.

4 | Investments

| Total £
Cost or valuation
Additions | 3,063,989
Provision
Carrying amount
At 31 July 2025 | 3,063,989

Details of undertakings

Details of the investments (including principal place of business of unincorporated entities) in which the company holds 20% or more of the nominal value of any class of share capital are as follows:

Undertaking | Registered office | Holding | Proportion of voting rights and shares held
|  |  | 2025 |
Subsidiary undertakings
Registry Surgery Limited | 105 Humber Road Blackheath London England SE3 7LW England and Wales |
Ordinary A
Ordinary B
100%
100%

Subsidiary undertakings
Registry Surgery Limited The principal activity of Registry Surgery Limited is the provision of veterinary services.

Old Registry DNA Vetcare Ltd

Notes to the Abridged Financial Statements for the Period from 9 September 2024 to 31 July 2025

5 | Related party transactions

The company has taken advantage of the exemption available under Section 33 of FRS 102 Related Party Disclosures, and has not disclosed transactions or balances with related parties that are part of the group. This is on the grounds that it is a wholly-owned subsidiary of DNA Vetcare Limited, which prepares consolidated financial statements that are publicly available and include the results of the company.
The consolidated financial statements of DNA Vetcare Limited can be accessed online at Companies House.

6 | Parent and ultimate parent undertaking

The company's immediate parent is DNA Vetcare Limited, incorporated in England and Wales.
These financial statements are available upon request from
105 Humber Road
Blackheath
London
SE3 7LW